BI 695501 Versus Humira® in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Exploratory Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010197/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Primary Objective:
The primary objective of this trial is to compare the clinical efficacy of BI 695501 with
EU-approved Humira® in patients with active Crohn's disease (CD).
Secondary Objectives:
The secondary objectives of this trial are to compare the efficacy and safety of BI 695501
with EU-approved Humira® across the induction and maintenance phases.
提供机构：
Vivli
创建时间：
2024-06-13
